ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CRK proteins are prevalent phosphorylation substrates for the BCR-ABL fusion oncogene and are found in more than 95% of CML and 20% to 30% of acute lymphoblastic leukemia cases.